References
- Centers for Disease Control and Prevention. Mpox. https://www.cdc.gov/poxvirus/monkeypox/index.html. Accessed January 5, 2023.
- Guarner J, Del Rio C, Malani PN. Monkeypox in 2022-what clinicians need to know. JAMA. July 12, 2022;328(2):139–140. doi:10.1001/jama.2022.10802.
- Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus infection in humans across 16 countries — April–June 2022. N Engl J Med. 2022;387(8):679–691. doi:10.1056/NEJMoa2207323.
- Happi C, Adetifa I, Mbala P, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. August 23, 2022;20(8):e3001769. doi:10.1371/journal.pbio.3001769.
- European Centre for Disease Prevention and Control. Factsheet for health professionals on Mpox (monkeypox). https://www.ecdc.europa.eu/en/all-topics-z/monkeypox/factsheet-health-professionals. Accessed January 5, 2023.
- Cash-Goldwasser S, Labuda SM, McCormick DW, et al. Ocular Monkeypox — United States, July–September 2022. MMWR Morb Mortal Wkly Rep. October 21, 2022;71(42):1343–1347. doi:10.15585/mmwr.mm7142e1.
- Kyaw NTT, Kipperman N, Alroy KA, et al. Notes from the field: clinical and epidemiologic characteristics of Mpox cases from the initial phase of the outbreak — New York City, May 19–July 15, 2022. MMWR Morb Mortal Wkly Rep. December 30, 2022;71(5152):1631–1633. doi:10.15585/mmwr.mm715152a3.
- Kaufman AR, Chodosh J, Pineda R. Monkeypox virus and ophthalmology-a primer on the 2022 Monkeypox outbreak and Monkeypox-related ophthalmic disease. JAMA Ophthalmol. November 3, 2022;141:78. doi:10.1001/jamaophthalmol.2022.4567.
- Finamor LPS, de Freitas D, Andrade G, et al. Tecovirimat treatment for Monkeypox virus keratouveitis. JAMA Ophthalmol. December 22, 2022;141:210. doi:10.1001/jamaophthalmol.2022.5486.
- Lamas-Francis D, Treviño M, Pérez-Freixo H, Martínez-Perez L, Touriño R, Rodríguez-Ares T. Corneal ulcer due to Monkeypox infection. Ocul Immunol Inflamm. December 12, 2022;1–3. doi:10.1080/09273948.2022.2153343.
- Alsarhani WK, Chan CC, Boyd SR, Hasso M, Almeer A, Tan DHS. Monkeypox-associated disciform keratitis. 2022;42:641–644. doi:10.1097/ICO.0000000000003171.
- Uner OE, Hubbard DC, Torres-Quinones C, et al. Human Mpox (monkeypox) virus membranous keratoconjunctivitis with transient corneal hypoesthesia and late symblepharon formation: a novel case and clinical implications. Cornea. 2023. doi:10.1097/ICO.0000000000003231.
- Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. August, 1987;156(2):293–298. doi:10.1093/infdis/156.2.293.
- Foos W, Wroblewski K, Ittoop S. Subconjunctival nodule in a patient with acute Monkeypox. JAMA Ophthalmol. September 7, 2022;140:e223742. doi:10.1001/jamaophthalmol.2022.3742.
- Tabbara KF, Chavis PS. Herpes simplex anterior uveitis. Int Ophthalmol Clin. 1998;38(4):137–147. doi:10.1097/00004397-199803840-00013.
- Matias WR, Koshy JM, Nagami EH, et al. Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open Forum Infect Dis. 2022;9:ofac377. doi:10.1093/ofid/ofac377.
- European Medicines Agency. Tecovirimat SIGA. https://www.ema.europa.eu/en/medicines/human/EPAR/tecovirimat-siga. Accessed January 5, 2023.
- Altmann S, Brandt CR, Murphy CJ, et al. Evaluation of therapeutic interventions for vaccinia virus keratitis. J Infect Dis. March 1, 2011;203(5):683–690. doi:10.1093/infdis/jiq103.
- Bragazzi NL, Khamisy-Farah R, Tsigalou C, Mahroum N, Converti M. Attaching a stigma to the LGBTQI+ community should be avoided during the monkeypox epidemic. J Med Virol. June 2, 2022;95. doi:10.1002/jmv.27913.